Loading clinical trials...
Loading clinical trials...
Treatment Satisfaction and Effectiveness of Lurasidone on Quality of Life and Functioning in Adult Patients With Schizophrenia Treated in the Real World Italian Clinical Practice
The study is a multicentric, national, non-interventional, prospective, single arm study. The main goal of this study is to gather information about the effects, in a real-life setting, of lurasidone treatment on patient's reported outcomes, in terms of patient's treatment satisfaction, Quality of Life and functioning changes after 6 weeks from lurasidone treatment initiation in schizophrenia patients naïve to lurasidone.
Important aim of the study is to investigate, aspects related to effectiveness, safety and tolerability at 3 months' lurasidone treatment in a routine practice in Italian clinical settings. Only patients with primary diagnosis of schizophrenia who are prescribed lurasidone was evaluated for inclusion in the study.
Age
18 - 99 years
Sex
ALL
Healthy Volunteers
No
ASST degli Spedali Civili di Brescia
Brescia, Italy
Villa Von Siebenthal
Genzano di Roma, Italy
Azienda Sanitaria Azienda ospedaliero-universitaria Senese
Siena, Italy
Start Date
October 21, 2022
Primary Completion Date
September 12, 2023
Completion Date
September 12, 2023
Last Updated
August 1, 2024
61
ACTUAL participants
Lurasidone
DRUG
Lead Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Collaborators
NCT07455929
NCT06740383
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions